Addiction Issues: Cannabis Update 2019
Questions, assessments and recommendations for a contemporary cannabis policy. The Swiss Federal Commission on Narcotic Drugs (EKSF) has worked through current issues relating to cannabis and cannabis use, building on the 1999 and 2008 cannabis reports of its predecessor commission (Federal Commission on Narcotic Drugs EKDF).
©Depositphotos/OpenRangeStock
Today publishes the EKSF Four reports with relevant findings from different perspectives: In the report "Cannabis: Mise à jour des connaissances 2019", based on interviews with experts, new findings on a broad selection of aspects that are Cannabis use and evaluated.
"Revue international des modèles de régulation du cannabis" highlights examples of cannabis handling and legislation at the international level.
"Cannabis Policy. Die Fragen die niemand stellt"/ Politique en matière de Cannabis. Les questions que personne ne pose" addresses problems that arise from the current legislation.
The results of these three reports are integrated in the "Synthesebericht Cannabis der Eidgenössischen Kommission für Suchtfragen EKSF " / "Rapport de Synthèse sur le Cannabis de la Commission fédérale pour les questions liées aux addictionens CFLA". Recommendations of the commission for the future handling of cannabis in Switzerland are formulated there.
Since the two publications of the EKDF (1999 and 2008), knowledge about the hemp plant and the psychoactive substances derived from it (various cannabinoids) has greatly expanded. The Legalization of cannabis in various countries has enabled the development of regulated markets, professionalization of production, and a variety of cannabis-based products. Research on the therapeutic use of cannabis has made considerable progress, and interest in expanded treatment options is high. The available research also shows that the use of cannabis has remained practically stable in Switzerland over the last decade. All scientific studies on the risks from use show that cannabis causes little physical or psychological harm. What is risky is mainly the use of products with a high THC content, smoked with tobacco, use in childhood and early adolescence, and long-term use. The good work of prevention and treatment has been confirmed in the last 10 years. However, developments and patterns of use show that it is even more important to develop harm-reduction approaches for cannabis users. However, the existing prohibition prevents harm- and risk-reducing measures as well as the expansion of prevention measures.
More info
